Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer
Authors
Keywords
-
Journal
ONCOGENE
Volume 31, Issue 41, Pages 4460-4471
Publisher
Springer Nature
Online
2012-01-24
DOI
10.1038/onc.2011.624
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Continued Androgen Receptor Signaling in Prostate Cancer
- (2011) C. Massard et al. CLINICAL CANCER RESEARCH
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
- (2011) Biswajyoti Sahu et al. EMBO JOURNAL
- Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer
- (2011) A Urbanucci et al. ONCOGENE
- Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer
- (2011) E S Martens-Uzunova et al. ONCOGENE
- BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity
- (2010) Xu-Dong Hu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray
- (2010) Elin Möllerström et al. BMC CANCER
- Integrative Genomic Profiling of Human Prostate Cancer
- (2010) Barry S. Taylor et al. CANCER CELL
- Association of SPINK1 Expression and TMPRSS2:ERG Fusion with Prognosis in Endocrine-Treated Prostate Cancer
- (2010) K. A. Leinonen et al. CLINICAL CANCER RESEARCH
- MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression
- (2010) Yasunori Fujita et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The PI3K Pathway As Drug Target in Human Cancer
- (2010) Kevin D. Courtney et al. JOURNAL OF CLINICAL ONCOLOGY
- Mammalian microRNAs predominantly act to decrease target mRNA levels
- (2010) Huili Guo et al. NATURE
- Androgen regulation of micro-RNAs in prostate cancer
- (2010) Kati K. Waltering et al. PROSTATE
- miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
- (2010) T Murata et al. PROSTATE CANCER AND PROSTATIC DISEASES
- Roles of small RNAs in tumor formation
- (2010) Gianpiero Di Leva et al. TRENDS IN MOLECULAR MEDICINE
- Reactivation of Androgen Receptor-Regulated TMPRSS2:ERG Gene Expression in Castration-Resistant Prostate Cancer
- (2009) C. Cai et al. CANCER RESEARCH
- miR-21: An Androgen Receptor-Regulated MicroRNA that Promotes Hormone-Dependent and Hormone-Independent Prostate Cancer Growth
- (2009) J. Ribas et al. CANCER RESEARCH
- Increased Expression of Androgen Receptor Sensitizes Prostate Cancer Cells to Low Levels of Androgens
- (2009) K. K. Waltering et al. CANCER RESEARCH
- The Role of microRNA-221 and microRNA-222 in Androgen-Independent Prostate Cancer Cell Lines
- (2009) T. Sun et al. CANCER RESEARCH
- MicroRNAs: Target Recognition and Regulatory Functions
- (2009) David P. Bartel CELL
- ETS Gene Fusions in Prostate Cancer: From Discovery to Daily Clinical Practice
- (2009) Scott A. Tomlins et al. EUROPEAN UROLOGY
- The mammalian anti-proliferative BTG/Tob protein family
- (2009) G. Sebastiaan Winkler JOURNAL OF CELLULAR PHYSIOLOGY
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
- (2008) S. Ambs et al. CANCER RESEARCH
- TMPRSS2:ERG Fusion Identifies a Subgroup of Prostate Cancers with a Favorable Prognosis
- (2008) O. R. Saramaki et al. CLINICAL CANCER RESEARCH
- Most mammalian mRNAs are conserved targets of microRNAs
- (2008) R. C. Friedman et al. GENOME RESEARCH
- TCEB1promotes invasion of prostate cancer cells
- (2008) Sanni E. Jalava et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I Clinical Trial of a Selective Inhibitor of CYP17, Abiraterone Acetate, Confirms That Castration-Resistant Prostate Cancer Commonly Remains Hormone Driven
- (2008) Gerhardt Attard et al. JOURNAL OF CLINICAL ONCOLOGY
- Proliferating Cells Express mRNAs with Shortened 3' Untranslated Regions and Fewer MicroRNA Target Sites
- (2008) R. Sandberg et al. SCIENCE
- Model-based Analysis of ChIP-Seq (MACS)
- (2008) Yong Zhang et al. GENOME BIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started